Deep Medicine Acquisition Corp.
NASDAQ:DMAQ
2.96 (USD) • At close January 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 | 0.046 | 0 |
| Gross Profit
| 0 | -0.015 | -0.015 | 0.075 | -0.015 | -0.015 | -0.015 | -0.015 | -0.015 | -0.015 | -0.015 | -0.046 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.833 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.369 | 0.327 | 0.328 | 0.549 | 0.4 | 0.718 | 0.27 | 0.177 | 0.138 | 0.079 | 0.016 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.369 | 0.327 | 0.328 | 0.549 | 0.4 | 0.718 | 0.27 | 0.177 | 0.138 | 0.079 | 0.016 | 0.059 | 0 |
| Other Expenses
| 0.047 | 0.034 | 0.059 | 0.2 | 0.015 | 0.015 | 0.015 | 0 | 0.015 | 0.015 | 0 | 0 | 0 |
| Operating Expenses
| 0.415 | 0.346 | 0.372 | 0.749 | 0.4 | 0.718 | 0.27 | 0.177 | 0.138 | 0.079 | 0.016 | 0.059 | 0 |
| Operating Income
| -0.36 | -0.27 | -0.262 | -0.86 | 0.646 | -1.837 | -0.516 | -0.179 | -0.153 | -0.094 | -0.031 | -0.105 | 0 |
| Operating Income Ratio
| 0 | 0 | 0 | -9.555 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0 | 0 | 0.111 | 0.192 | 1.061 | 1.671 | 0.361 | -0.004 | 0.002 | -0.079 | -0.016 | -0.059 | 0 |
| Income Before Tax
| -0.36 | -0.27 | -0.262 | -0.668 | 0.646 | -0.166 | -0.154 | -0.183 | -0.135 | -0.079 | -0.016 | -0.059 | 0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -7.427 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.111 | -0.011 | 0.068 | -0.567 | -0.13 | -0.009 | -0.017 | -0.094 | -0.031 | -0.105 | 0 |
| Net Income
| -0.36 | -0.27 | -0.262 | -0.658 | 0.577 | 0.402 | -0.024 | -0.175 | -0.135 | -0.079 | -0.016 | -0.059 | 0 |
| Net Income Ratio
| 0 | 0 | 0 | -7.307 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.083 | -0.062 | -0.057 | -0.28 | 0.04 | 0.024 | -0.002 | -0.02 | -0.011 | -0.005 | -0.001 | 0 | 0 |
| EPS Diluted
| -0.083 | -0.062 | -0.057 | -0.28 | 0.04 | 0.024 | -0.002 | -0.02 | -0.011 | -0.005 | -0.001 | 0 | 0 |
| EBITDA
| -0.36 | -0.361 | -0.483 | -0.86 | -1.476 | -1.27 | -0.385 | -0.171 | -0.14 | -0.079 | -0.016 | -0.059 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | -9.555 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |